GlassScriptPhysician profile
Shaileshkumar K Desai
NPI 1225046220
$802.21
in general payments reported to CMS, 2019-2025
13 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $28.57 · 2021: $202 · 2022: $58.93 · 2023: $15.23 · 2024: $127 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $512.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $221.41 | 2020-2022 | |
| Medtronic, INC. | $115.98 | 2025 | Cardioblate Gemini |
| Merck Sharp & Dohme LLC | $107.42 | 2024 | Verquvo |
| Pfizer INC. | $78.80 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $65.98 | 2020-2023 | |
| Lilly USA, LLC | $54.27 | 2025 | Kisunla, Mounjaro, Zepbound |
| Otsuka America Pharmaceutical, INC. | $41.00 | 2025 | Rexulti |
| Corcept Therapeutics | $35.09 | 2025 | Korlym |
| Novo Nordisk INC | $28.27 | 2025 | Rybelsus, Ozempic |
| Edwards Lifesciences Corporation | $22.59 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Exact Sciences Corporation | $14.29 | 2025 | The Cologuard Plus Collection Kit |
| Vivaquant INC, Dba Rhythm Express | $12.00 | 2025 | Rhythm Express |
| Tms Neurohealth Centers INC. | $5.11 | 2025 | Tms Neurohealth Centers INC. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaileshkumar Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.